首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2945篇
  免费   200篇
  国内免费   8篇
耳鼻咽喉   18篇
儿科学   154篇
妇产科学   116篇
基础医学   367篇
口腔科学   45篇
临床医学   239篇
内科学   572篇
皮肤病学   101篇
神经病学   232篇
特种医学   171篇
外国民族医学   1篇
外科学   506篇
综合类   34篇
预防医学   170篇
眼科学   66篇
药学   162篇
中国医学   9篇
肿瘤学   190篇
  2023年   22篇
  2022年   28篇
  2021年   54篇
  2020年   25篇
  2019年   41篇
  2018年   58篇
  2017年   43篇
  2016年   68篇
  2015年   55篇
  2014年   71篇
  2013年   84篇
  2012年   128篇
  2011年   147篇
  2010年   69篇
  2009年   80篇
  2008年   138篇
  2007年   140篇
  2006年   176篇
  2005年   159篇
  2004年   150篇
  2003年   131篇
  2002年   102篇
  2001年   100篇
  2000年   73篇
  1999年   85篇
  1998年   29篇
  1997年   32篇
  1996年   35篇
  1995年   33篇
  1994年   32篇
  1993年   18篇
  1992年   65篇
  1991年   55篇
  1990年   60篇
  1989年   55篇
  1988年   42篇
  1987年   57篇
  1986年   41篇
  1985年   61篇
  1984年   34篇
  1983年   18篇
  1981年   12篇
  1980年   11篇
  1979年   34篇
  1978年   17篇
  1976年   16篇
  1975年   12篇
  1974年   11篇
  1973年   19篇
  1972年   12篇
排序方式: 共有3153条查询结果,搜索用时 15 毫秒
31.
The polymorphism of HLA-DR3 was investigated in families and unrelated individuals of three population groups: South African (SA) Negroes, Cape Coloureds and SA Caucasoids. Serological and restriction fragment length polymorphism (RFLP) analysis indicated that DR3 could be subdivided into DRw17 (previously DR3.1) and DRw18 (previously DR3.2). In contrast, the two-dimensional (2-D) gel electrophoresis patterns could not distinguish between the DRB1 gene products of the HLA-DRw17 and DRw18 cells. Two DRB3 variants, correlating with the T-cell defined specificities Dw24 and Dw25 were identified at the genomic and product level. Of ten haplotypes studied with the newly defined HLA-DRw18 specificity, all had the DRB3 RFLP pattern associated with Dw24. HLA-DRw17 was found in all three population groups tested, although in the SA Negroes HLA-DRw18 was the prevalent DR3 subgroup. This subgroup was also present in the Cape Coloureds but was absent in the SA Caucasoid tested. HLA-DRw18 forms part of the most characteristic SA Negro haplotype, Bw42, DQw4, Dw“RSH,” while HLA-DRw17 is part of the classic Caucasoid haplotype, B8, DQw2, Dw3.  相似文献   
32.
33.
Abstract. Idiopathic pulmonary fibrosis (IPF), synonymous with cryptogenic fibrosing alveolitis (CFA), is a progressive and usually fatal disease of unknown cause characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. Historically, IPF/CFA encompassed a heterogeneous group of different histological and clinical entities arising in an idiopathic setting. Recently, the American Thoracic Society (ATS) and European Respiratory Society (ERS) core committee has redefined diagnostic criteria for both IPF/CFAand idiopathic interstitial pneumonias confining the term IPF/CFA to patients with a histological pattern of usual interstitial pneumonia on lung biopsy. This review attempts to refine the clinico-radiological-pathological features that together define IPF/CFA as it is understood today, and to summarize the rationale of new therapeutic approaches based on the current understanding of the pathogenetic mechanisms.  相似文献   
34.
35.
Congenital palpebral ptosis is a disease which make problems about surgery timing and surgical method used. A child, three years old, presents partial palpebral ptosis at left eye after congenital paresis of the oculomotor common nerve. Ocular statistical exam underlines one deviation by ten degrees and dorsal vergence by fifteen degrees at left eye. After covering the right eye, the left eye assumes fixation and the upper eyelid elevates. On practise liberality of the right superior muscle at the right eye (Faden method and recoil by 5 mm), which establishes the disparition of the left eye deviation and of the ptosis. Orthoptic exam must direct the decision about the surgical method in these situations.  相似文献   
36.
37.
38.
J. Moon  R. M du Bois  T. Colby  D. Hansell    A. Nicholson 《Thorax》1999,54(11):1009-1014
BACKGROUND: Respiratory bronchiolitis-associated interstitial lung disease (RBILD) is a rare form of interstitial lung disease which may present in similar fashion to other types of chronic interstitial pneumonia. The purpose of this study was to undertake a clinicopathological review of 10 patients with RBILD and to examine the clinical and imaging data related to its histopathological pattern, in particular the relationship of RBILD to smoking. METHODS: Thirteen out of 168 retrospectively reviewed patients, from whom biopsy specimens were taken for suspected diffuse lung disease, were identified with a histopathological pattern of RBILD. Three cases were rejected as follow up data were unavailable. The 10 remaining cases constituted the study group and both clinical and imaging data were collected from patients' notes and referring physicians. RESULTS: Histopathologically, four cases of RBILD overlapped with the pattern of desquamative interstitial pneumonitis (DIP) and nine also had microscopic evidence of centrilobular emphysema. Nine patients were smokers, ranging from 3 to 80 pack years. The one non-smoker had an occupational exposure to the fumes of solder flux. The sex distribution was equal with an age range of 32-65 years. Two patients were clubbed. Lung function tests showed both restrictive and obstructive patterns together with severe reductions in carbon monoxide transfer factor in seven patients. Chest radiographs showed reticular or reticulonodular infiltrates in five patients and a ground glass pattern in two. CT scans were consistent with either DIP or RBILD in six of eight patients. Although seven patients remained stable or improved, either with or without treatment, three patients deteriorated. CONCLUSIONS: This study adds weight to the hypothesis that smoking can cause clinically significant interstitial lung disease, with deterioration in pulmonary function despite treatment. Given the overlapping histopathological patterns of RBILD and DIP and their strong association with smoking, the term "smoking related interstitial lung disease" is suggested for those patients who are smokers.  相似文献   
39.
This study assessed the influence of dose and route of administration on salbutamol kinetics and hypokaliemic effect. Salbutamol plasma kinetics were studied in a first group of 6 rabbits who received 60, 800, and 60 g/kg by the intravenous (iv), oral (po), and intratracheal (it) routes, respectively, at 1-week intervals. A second group of 6 rabbits received 120, 2400, and 120 g/kg of salbutamol by the same three routes. Multiple blood samples were withdrawn to assay salbutamol and potassium. Following iv salbutamol (60 g/kg), total plasma clearance was 82±5 ml/min per kg, apparent volume of distribution was 5.0±0.5 l/kg, and terminal half- life was 41±2 min. Similar values were estimated when 120 g/kg of salbutamol was administered iv or was given po or it. The bioavailability of po and it salbutamol was approximately 1 and 20%, respectively. For the first group, the maximal decrease in plasma potassium elicited by salbutamol was 0.80±0.19, 0.48±0.22, and 0.78±0.46 mmol/l, and for the second group, maximal decrement was 1.31±0.37, 0.70±0.24, and 0.84±0.17 mmol/l for the iv, po, and it routes, respectively. Compared to salbutamol peak plasma concentrations, maximal decrease in plasma potassium appeared between 60 and 108 min later for the iv route, 90 and 25 min later for po and it routes, and for this reason, the hypokaliemic effect was not associated to salbutamol plasma concentrations. The hypokaliemic effect was dependent upon the route, e.g., po>it>iv. It is concluded that (i) salbutamol plasma kinetics are first-order independently of the route of administration, and (ii) salbutamol hypokaliemic effect is modulated by the dose and the route of administration.List of abbreviations AUC Area under salbutamol plasma concentration-time curve - clINT Salbutamol intrinsic clearance - clT Salbutamol total plasma clearance - cMAX Salbutamol maximal plasma concentration - F Fraction of the dose of salbutamol reaching the systemic circulation - iv Intravenous route of administration - it Intratracheal route of administration - po Oral route of administration - Varea Salbutamol apparent volume of distribution - T 2 1 Salbutamol half-life of the terminal phase - tMAX Time to observe the maximal decrease in plasma potassium - eMAX Predicted maximal effect of salbutamol - EC50 Concentration of salbutamol eliciting 50% of eMAX Supported by the Medical Research Council of Canada (MT-10874). Sylvie Perreault is recipient of a Bourse Formation de troisième cycle des Fonds de la Recherche en Santé du Québec.  相似文献   
40.
Summary A survey conducted in four French regions identified a sample of 154 autistic children born in the birth cohorts 1972 and 1976. Their mean ages were respectively 6.9 and 5.5 years when their handicaps were registered to local administrative services. The overall prevalence estimate is 4.9/10,000, with little difference between the two cohorts. The boy/girl sex ratio is 2.11, and more than two thirds are mentally retarded. The SES distribution does not deviate from census data. An elevated incidence of epilepsy is found (22%), with higher rates among the most retarded subjects and those with perinatal antecedents. Otherwise, relatively few autistic subjects were reported to have a clearcut medical disorder known for its association with autism.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号